Genprex (GNPX): Rep. Tim Moore (NC14) disclosed a purchase $15K–$50K
Rep. Tim Moore (NC14) disclosed a purchase of Genprex in the $15K–$50K range.
- $15,001–$50,000
- Reported range · official band, not an exact amount
- 14 days
- Disclosure lag
- Traded
- Oct 29, 2025
- Disclosed
- Nov 12, 2025
What stands out in this filing
- GNPX closed at $146.08 on Oct 29, 2025, at its 52-week low, after a 43% drop over the previous 30 trading days.
- Disclosed 14 days after the trade.
- Owner named on the report: Filer.
- The first disclosure on GNPX by this member on file.
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 13, 2025Company filing · Form 8-K · Listing notice, Shareholder rightsReceived a notice from its stock exchange, and changed the rights of its shareholders (and 3 more items)“On October 13, 2025, the Nasdaq Hearings Panel (the “Panel”) notified Genprex, Inc. (the “Company” or “Genprex”) that it has granted the Company’s request for an exception to demonstrate compliance with the $1.00 Minimum Bid Price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Requirement”) and the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market,…”
- Oct 23, 2025Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 1 more item)
- Oct 28, 2025Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 1 more item)
- Oct 29, 2025 · this disclosureCongressDisclosed purchase of GNPX — reported range $15,001 - $50,000
What came next
- Nov 7, 2025CongressDisclosed purchase of GNPX — reported range $1,001 - $15,000
- Nov 25, 2025Company filing · Form 8-K · Listing noticeReceived a notice from its stock exchange“As previously disclosed, the Nasdaq Hearings Panel (the “Panel”) of the Nasdaq Stock Market, LLC (“Nasdaq”) had previously notified the Company on October 13, 2025 that the Panel had granted the Company’s request for an exception to demonstrate compliance with the $1.00 Minimum Bid Price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Requirement”) and the minimum stockholders’ equity…”
- Dec 18, 2025CongressDisclosed purchase of GNPX — reported range $1,001 - $15,000
- Feb 5, 2026CongressDisclosed purchase of GNPX — reported range $1,001 - $15,000
How to read House Clerk periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for Genprex
OQRO holds no insider, Congress, fund or contract record for Genprex dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its GNPX page.
Other recent filings by Rep. Tim Moore (NC14)
- House Clerk periodic transaction report at AT&T (T)Aug 20, 2026
- House Clerk periodic transaction report at DoorDash (DASH)Jul 9, 2026
- House Clerk periodic transaction report at AT&T (T)Jun 5, 2026
- House Clerk periodic transaction report at AT&T (T)Jun 5, 2026
- House Clerk periodic transaction report at AT&T (T)May 19, 2026
The full history of Rep. Tim Moore (NC14) is on the profile page.
How this filing works
Explore the data
Common questions
Which member of Congress traded Genprex (GNPX) stock, and how much?
Rep. Tim Moore (NC14) disclosed a purchase of Genprex in the $15K–$50K range. Reported range, not an exact amount.
When did it happen, and when was it made public?
Traded: Oct 29, 2025. Disclosed: Nov 12, 2025. That is 14 days between the two dates.
What stands out in this filing?
GNPX closed at $146.08 on Oct 29, 2025, at its 52-week low, after a 43% drop over the previous 30 trading days. Disclosed 14 days after the trade. Owner named on the report: Filer.
Why is the amount a range and not an exact figure?
Members of Congress report each trade in a bracket set by law ($1,001 to $15,000, $15,001 to $50,000, and so on), never an exact amount. OQRO keeps the bracket as filed and does not estimate a figure inside it.
Where does this information come from?
From the House Clerk periodic transaction report, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
Does this mean GNPX stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Genprex
- SEC Form 4Apr 15, 2026
- SEC Form 4Apr 15, 2026
- House Clerk periodic transaction reportFeb 20, 2026
- House Clerk periodic transaction reportJan 7, 2026
- House Clerk periodic transaction reportDec 2, 2025
Everything OQRO holds on this company is on its GNPX page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
